Waud Capital Partners, a middle-market private equity firm, has announced an executive partnership with Bill Mixon, a veteran leader within the Complex Rehab Technology (CRT) and home medical equipment (HME) segments.
Waud Capital and Mixon will “pursue a platform investment in the medical device and supply chain services market,” Waud Capital said in a July 17 announcement. “Targeted sub-sectors of focus will include but are not limited to home distribution, other value-add specialty distribution, outsourced provider equipment services, and chronic care and population health management offerings that deliver value to supply chain channel partners.”
The company added that it expects to invest more than $100 million of equity capital on this new project.
Mixon is well known in the health-care industry, particularly in segments that focus on supporting patients in their homes. Most recently, Mixon was the CEO of Advanced Diabetes Supply Group (ADSG), which was acquired by Cardinal Health in November 2024. That transaction was completed in April, and Mixon left ADSG in mid July.
Prior to that, Mixon served for nine years as CEO of National Seating & Mobility, a CRT provider with locations across the United States and in Canada.
“We are thrilled to partner with Bill,” said Mike Lehman, principal, Waud Capital. “He is an exceptional executive who has created value and driven multiple successful outcomes throughout his career in a sector we find highly attractive. The health-care supply chain markets are highly fragmented with significant opportunities for organizations to deliver value-add solutions and address substantial challenges for key stakeholders.”
“I’m excited to partner with Waud Capital to identify and help build what we hope will be an industry-leading business that supports and improves the overall health-care supply chain,” Mixon added. “Waud Capital’s executive partnership approach, dedicated ecosystem resources, and deep investing experience across relevant areas make the firm a highly attractive partner. I believe this combination will enable us to capitalize on transformative growth opportunities, and I look forward to leveraging my past experiences to drive clinical value for medical professionals, manufacturers, payers and most importantly, patients.”
To date, Waud Capital’s health-care investments have included Mopec Group, a supplier of pathology technology, consumables and services; DS Medical, a home medical supplies provider; and PromptCare, a provider of home infusion and durable medical equipment.
